Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00144209
Recruitment Status : Completed
First Posted : September 5, 2005
Last Update Posted : November 1, 2013
Sponsor:
Information provided by:
Boehringer Ingelheim